1 completed, 1 enrolling by invitation, 1 unknown. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Enrolling by invitation 1, Unknown 1 |
| Phase 2 | 2 | Enrolling by invitation 1, Unknown 1 |
Follow Anti-Inflammatory Agents: new trials by email Literature Review of Anti-Inflammatory Agents trials Research Report on Anti-Inflammatory Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Autism Spectrum Disorder (ASD) Neurodevelopmental Disorder With Issues Social Behavior, Communication Issues, GI Dysfunction. Study is Multimodal Interventions Targeting These Pathways With cSVF, Stored MSCs, FMT and Diet Modification. Role of Autoimmunity, Gut-brain Issues, & Issues Examined. Autologous MSC isolation, concentration, and cryopreservation of adult mesenchymal stem cells, Fecal Biomicrome Transplantation (FMT), Ketogenic RESET Diet Protocol - Autism Spectrum Disorder, Autism | Phase 1 / Phase 2 | Enrolling by invitation | Black Tie Medical, Inc. | 50 | 2026-04-30 | 2026-04-27 |
| Study for the Prevention of Oral Mucositis (SPOM) Bocaliner, Benzydamine - Oral Mucositis | Phase 1 / Phase 2 | Unknown | E2Bio Life Sciences, LLC | 100 | 2022-04-15 | 2023-09-08 |
| A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62 SPI-62, Cortisone-d8 - Type 2 Diabetes Mellitus in Obese, Obesity | Phase 1 | Completed | Sparrow Pharmaceuticals | 12 | 2021-07-23 | 2024-04-22 |
Autism Spectrum Disorder (1) · Autistic Disorder (1) · Communication (1) · Inflammation (1) · Intestinal Diseases (1) · Learning Disabilities (1) · Obesity (1) · Oral Ulcer (1) · Pain (1) · Stomatitis (1)
Black Tie Medical, Inc. (1) · E2Bio Life Sciences, LLC (1) · Sparrow Pharmaceuticals (1)
United States (2) · Armenia (1)
David Katz, PhD (1) · Yervand Hakobyan, MD (1)